- Home
- HOFT vs UNCY Comparison
HOFT vs UNCY Comparison
Compare HOFT & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HOFT | UNCY |
|---|---|---|
| Founded | 1924 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 144.6M | 145.3M |
| IPO Year | 1999 | 2021 |
Fundamental Metrics
Financial Performance| Metric | HOFT | UNCY |
|---|---|---|
| Price | $15.40 | $5.50 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $25.67 |
| AVG Volume (30 Days) | 110.8K | ★ 2.6M |
| Earning Date | 04-16-2026 | 05-13-2026 |
| Dividend Yield | ★ 3.79% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $278,139,000.00 | $675,000.00 |
| Revenue This Year | $17.37 | N/A |
| Revenue Next Year | $9.00 | $582.86 |
| P/E Ratio | $155.70 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.62 | $3.72 |
| 52 Week High | $18.09 | $8.74 |
Technical Indicators
Market Signals| Indicator | HOFT | UNCY |
|---|---|---|
| Relative Strength Index (RSI) | 47.27 | 39.49 |
| Support Level | $15.08 | $4.73 |
| Resistance Level | $15.97 | $5.59 |
| Average True Range (ATR) | 1.04 | 0.77 |
| MACD | -0.23 | -0.21 |
| Stochastic Oscillator | 7.50 | 33.48 |
Price Performance
Historical ComparisonAbout HOFT Hooker Furnishings Corporation
Hooker Furnishings Corp is a designer, marketer and importer of casegoods (wooden and metal furniture), leather furniture, fabric-upholstered furniture, lighting, accessories, and home decor for the residential, hospitality and contract markets. It is also domestically manufactured premium residential custom leather, custom fabric-upholstered furniture, and outdoor furniture. The company operates in four segment Hooker Branded segment, Home Meridian segment, Domestic Upholstery segment and All Other.
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.